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SUMMARY
Research involving nerve transplantation has
shown that tissue rejection limits the neurologic
recovery unless the host is immunosuppressed.
This study investigates an alternative to perma-
nent or temporary immunosuppression using a
rat model with nerve transplants from Brown-
Norway rat donors to bridge defects in the sci-
atic nerve of Lewis rat recipients as these two
inbred strains differ at both major and minor
histocompatibility loci. The specific aim of this
study was to evaluate if predegenerated nerve
grafts decreased the tissue rejection and im-
proved the neurologic recovery of animals with
allogenic nerve grafts to avoid the problems as-
sociated with either short- or long-term im-
munosuppression. The animals in the experi-
mental groups received cyclosporin-A, predegen-
crated grafts, both, or neither. The predegener-
ated grafts were produced by division of the
nerve three weeks prior to grafting to allow for
Wallerian degeneration to occur. The outcome
was assessed by measurements stressing func-
tional recovery (sensory testing, gait analysis,
joint flexion contracture), studies of muscle re-
covery (muscle weight and hydroxyproline con-
centration), and histologic studies (axonal
counts and inflammatory reaction). The animals
receiving the predegenerated grafts without cy-
closporin did have an improved recovery (joint
flexion contracture 35 8 and hydroxyproline
ratio 1.52 +_. 0.16) as compared to the joint flex-
ion contractures and hydroxyproline ratios of
the allograft group of animals without either cy-
closporin-A or pretreatment and the ungrafted
control group (47 +_ 18, 1.68 +_ 0.34, and 53
_+ 15 4.50 +_ 0.27, respectively, p < 0.01). How-
ever, all the isograft groups and allograft groups
with cyclosporin-A, regardless of whether the
graft had been predegenerated or not, had
greater neurologic recovery than the allograft
group with predegenerated grafts but without
cyclosporin-A by the same parameters (p <
0.01). Allograft groups with short-term im-
munosuppression with cyclosporin-A did as well
as isograft groups, and isograft groups with pre-
degenerated grafts did not do any better than
isografts without pretreatment (p < 0.01).
Clinical Relevance: Predegenerated nerve allo-
grafts will allow for greater neurologic recovery
than standard nerve allografts avoiding the
complications of immunosuppression, but the
level of recovery is less than that of recipients of
nerve allografts with immunosuppression. Nerve
transplants would avoid the problems of neuro-
logic deficits at the donor site and allow multiple
large deficits to be treated easily.
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nerve, transplant, immunology, allograft, Walle-
rian degeneration
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INTRODUCTION
Currently, peripheral nerve injuries are
treated by autogenous nerve grafts frequently
obtained from areas such as the sural nerve.
Many techniques have been explored to over-
come these segmental deficits in peripheral
nerves without requiring the use of autogenous
grafts. With autogenous grafts, there is an obliga-
tory neurologic deficit at the donor site plus the
problem of a limited supply of graft material
when treating large peripheral nerve injuries.
Despite techniques using synthetic or fibrous
sheath grafts, there is limited regeneration for
segmental gaps in nerves greater than one cen-
timeter. Thus, nerve cable grafts are still the
most effective way to treat segmental injuries in
peripheral nerves. Allogeneic transplantation of
peripheral nerves would overcome these prob-
lems; however, neurologic recovery with allo-
geneic grafts has been limited by tissue rejection
/1-4/. Early efforts to avoid the rejection
phenomena have centered on decreasing the
immunogenicity of the graft or attenuating the
host response to the graft /4-8/. The Schwann
cells are the immunogenic component of the
nerve/19/. Freezing the grafts or treating them
with high doses of radiation does limit the rejec-
tion response to nerve allografts. However, this
technique eliminates the viable Schwarm cells
and drastically reduces the neurologic recovery
when these tissues are used for grafting /6-
8,10,11,20/. Host immunosuppression has been
accomplished using chemotherapy using corti-
costeroids, azathioprine, and cyclosporin-A,
either with short-term or long-term treatment
/7,9,11-16/. However, even short-term immuno-
suppression presents a serious risk to the host in
terms of hepatic and renal toxicity as well as
limiting the overall neurologic recovery. This
study investigates graft pre-treatment using
nerve graft segments that have undergone Wal-
lerian degeneration as a means of improving the
neurologic recovery of animals following trans-
plantation without the need for immuno-
suppression. During Wallerian degeneration the
Schwann cells are transformed to phagocytic
cells that may have decreased expression of anti-
genic markers. This study stresses the functional
recovery of the animal, as techniques which
primarily emphasize histologic or electrophysio-
logic parameters do not correlate with para-
meters that are useful clinically/8,9,18-26/.
MATERIALSAND METHODS
Animal model
Adult male rats were used in order to
minimize the possibility of hormonal changes
during the experiments that could affect results
of transplantation. Brown-Norway rats (250-300
g, Harlan Sprague-Dawley, Indianapolis, IN)
served as the donors and Lewis rats (300-350 g,
Charles River Breeding Laboratory, Bedford,
MA) served as the recipients and donors. These
strains have been shown to differ in both major
and minor histocompatibility loci/27/. The rats
were maintained in separate facilities in order to
prevent viral contamination as there is a signifi-
cant degree of microbial incompatibility between
the two strains. The animals were assigned to
one of eight experimental groups (n = 15 for
each group; Table 1). Dependent on the group
that they were assigned to, the animals in Groups
A through G received nerve grafts either with or
without pretreatment by Wallerian degenera-
tion, temporary host immunosuppression, both
or neither. The Group H was left ungrafted as a
control after a 2.0 cm defect was made in the
sciatic nerve.
TABLE 1
Transplantation protocol
Cyclo- Wallerian
Group Recipient Donor sporin-A Degeneration
A Lewis Lewis 0
B Lewis Lewis + 0
C Lewis Lewis *
D Lewis Brown-Norway 0
E Lewis Brown-Norway + 0
F Lewis Brown-Norway *
G Lewis Brown-Norway + *
H Lewis Gap None None
no cyclosporin treatment given
+ cyclosporin treatment given
0 no predegeneration of the graft
* graft pretreated with Wallerian degeneration
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Predegenerated grafts were obtained by divi-
sion of the sciatic nerve approximately three
weeks prior to the final graft harvest. The
animals were anesthetized with 30-50 mg/kg of
pentobarbital sodium (Abbott Laboratories,
Quebec, Canada) administered intraperi-
toneally. Under aseptic technique, a gluteal
muscle splitting incision was made to expose the
sciatic nerve. The nerve was then divided just as
it exits from the sciatic notch. The wound was
then closed in two layers with adsorbable
sutures. After three weeks, a 2.5 cm segment was
removed for nerve grafting using the same surgi-
cal technique to place a 2.5 cm graft into a 2.0
cm. defect coapting the ends using standard
microsurgical technique with 10-O nylon.
The animals in Groups B, E and G received
cyclosporin-A orally in an olive oil suspension
(Sandoz Inc., East Hanover, NJ) delivered by
gavage (10 mg/kg/day) for twelve weeks. The
animals were then maintained for another four
weeks prior to sacrifice as rejection of peripheral
nerves occurs within three weeks in the absence
of immunosuppression or host incorporation
/12,14/. This dose of cyclosporin has been
demonstrated to be effective without causing
significant toxicity /28/. Animals in the control
groups received olive oil alone. At the conclusion
of the 16 weeks, the animals were sacrificed after
the final testing was performed in order to
remove the nerve graft along with 5 mm of the
host nerve on either end, the contralateral nerve,
the tibialis anterior muscle from the operated
limb and the tibialis anterior muscle from the
non-operated limb.
Sensory testing
The animals’ response to light touch pressure
and pin prick were recorded as follows: Grade 0
(no response), Grade 1 (withdrawal behind limb
less than 1.0 cm), and Grade 2 (withdrawal more
than 1.0 cm). The animals were tested before
and after the sciatic nerve was blocked with 1%
lidocaine or the animals were lightly anes-
thetized using 10-20 mg/kg of pentobarbital
intraperitoneally. Light touch was assessed with
Semmes-Weinstein filaments. Pressure was de-
termined using a clamp calibrated at 30 g/cm2.
Gait testing and flexion contracture assessment
The sciatic function index (SFI) described by
deMedinaceli et al. /29/was carried out on all
animals. This is a combined scoring system that
applies a formula using measurements .from
pawprints of toe spread and stride length. The
toe spread has been noted to be the most reli-
able indicator in the gait analysis /30/. As in a
previous study, the animals in the experimental
groups were noted to have insufficient recovery
of foot intrinsic muscles to allow for reproducible
gait patterns within the experimental groups.
Therefore, a technique of assessing functional
recovery through the measurement of flexion
contracture of the hind limbs was incorporated
/31/. Under light general anesthesia, passive
motion in the operated and unoperated leg was
determined by suspending a 10 g weight from the
foot and measuring the degree of ankle exten-
sion with a goniometer. This weight was suffi-
cient to elicit the maximum joint extension.
Control animals with only the muscle splitting
incision did not develop any joint contracture.
The degree of flexion contracture was defined as
the difference between the passive extension of
the normal and operated sides.
Tibialis anterior muscle weight and hydroxy-
proline assay
The tibialis anterior (TA) muscle was har-
vested from both hind limbs at the time of sacri-
fice. The muscle was removed in its entirety and
weighed to the nearest 0.0001 g (Sartorius
Analytic Balance Model 2603, Munich, West
Germany). The muscle weight data were repor-
ted as a ratio of the operated leg to that of the
unoperated limb.
The muscle hydroxyproline content was de-
termined using the technique described by
Woessner/32/. Muscle samples were hydrolyzed,
oxidized using chloramine T (Fisher 01770,
Reagent Grade, Fisher Chemicals, Kent, Wash-
ington) and the color was analyzed spectro-
photometrically (LKB Biochron Ultraspec 4050,
AB Bromma, Sweden), following the addition of
the developer, dimethylaminebenzaldehyde, and
using an adsorbency of 561 nm. Distribution of
hydroproline was restricted to the scleroproteins,
collagen and elastin, pattern of muscle fibrosis
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which increases the content of the scleroproteins
in muscle/33/. The results were reported as the
ratio of hydroxyproline concentration in the
muscle of the operated side to that of the un-
operated control limb.
Histologic studies
Four months following the nerve grafting, the
animals were re-explored in order to harvest the
graft segments along with portions of the host
nerve and the contralateral nerve. The segments
were immersed in Karnovsky’s fixative, washed
in cacodilated buffer, post-fixed with 1% osmium
tetraoxide, dehydrated in graded alcohols, and
embedded in epon. Sections one micron in
thickness were prepared using an ultramicro-
tome (LKB Huxley, AB Bromma, Sweden) with
a glass knife. Axon counts were performed using
a Zeiss Videoplan (Munich, West Germany)
with custom software for the calculation of area
and point counting. The results were expressed
as the ratio of the density (axon/mmz) of the
fibers and the graft to the density in contralateral
nerve. The Videoplan was also used to assess the
relative histologic specimens that had infiltration
by inflammatory cells on cross-sections from the
mid point of the graft.
Serum cyclosporin-A assay
Serum cyclosporin-A levels were determined
four weeks following the onset of the immuno-
suppressant therapy using a commercially avail-
able immunoassay for cyclosporin-A (Cyclo-
Trac, Incstar Corporation, Stillwater, MN). This
technique is based on an equilibration procedure
using double antibody phase separation and an
iodine25 tracer. The parent molecule and its
nine biologically active metabolites are
measured by this technique.
Statistical analysis
An analysis of variance was conducted within
and among different experimental groups by
means of the Kruskal-Wallis ANOVA non-
parametric test. Individual comparisons in the
groups were tested for probabilities and levels of
significance by means of the Dunn analysis for
multiple comparisons using rank sums and
Student’s t-test where appropriate.
RESULTS
Sensory testing
Repeated testing with pressure pin-prick and
light touch did not reveal any consistency even
within experimental groups. Even groups having
reinnervation as assessed by the other
parameters had inconsistent results with the
sensory tests. Even the gap control animals
demonstrated some withdrawal response.
Anatomical studies have shown that crossover
innervation from the saphenous nerve is a
predictable phenomenon in rats after sciatic
nerve injury/34/. Our results seemed consistent
with this as there were occasional examples of
toe loss due to self-mutilation and this was
always the most lateral toe, which is farthest
from the distribution of the saphenous nerve.
Gait analysis and flexion contracture
As mentioned previously, the usefulness of
the gait analysis was questioned early in the
experiment when there was noted to be a lack of
return in the intrinsic muscles to the foot in all
grafted groups. Even after trying to modify the
SFI formula to emphasize either stride length or
toe spread, the gait analysis still did not provide
reproducible results within single groups. In
contrast to the use of the SFI when there is a
lesion in continuity /29,35/, efforts to base the
SFI on the stride length were hampered by the
fact that this parameter seems to be most heavily
influenced by the animal’s motivation.
Measurements of the flexion contracture
were reproducible within experimental groups
(Fig. 1). There was no significant difference
between any of the isografted groups or the
allografted groups which received cyclosporin-A.
Furthermore, there was no significant difference
between the allografted group which received
both cyclosporin-A and pretreated grafts (Group
G) versus the group with immunosuppression
but without the pretreated graft (Group E). The
group with the pretreated graft but no host
immunosuppression (Group F) had smaller
flexion contractures (35* __. 8*) when compared
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KEY TO FIGURES:
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Iso/CyA
Iso/Wall
AIIo
AIIo/CyA
AIIo/Wall
AIIo/CyA/Wall
Gap
isogenic grafts
isogenic grafts and host immunosuppression with cyclosporin-A
isogenic grafts that underwent Wallerian predegeneration
allogenic grafts without pretreatment or cyclosporin-A immunosuppression
allogenic grafts and host immunosuppression with cyclosporin-A
allogenic grafts that underwent Wallerian predegeneration
allogenic grafts that underwent Wallerian predegeneration and host immunosuppression with
cyclosporin-A
control animals that were not grafted.
FIGURE 1 FLEXION CONTRACTURES
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The hind limb flexion contracture in degrees is obtained by subtracting the total passive extension of the
operated limb from that of the unoperated limb.
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to the allografted group without pretreated
grafts (Group D, 47 _. 10) or the ungrafted
gap control group (Group H, 53 +_ 15, p <
0.01). However, the flexion contractures in
Group F were significantly larger than in the
remaining groups which had either isografts or
allografts with immunosuppression (p < 0.01).
Tibialis anterior
hydroxproline assay
muscle weight and
The results are reported as the ratio of the
tibialis anterior muscle weight in the operated
limb compared to the non-operated limb (Fig.
2). There were no significant differences in these
FIGURE 2- MUSCLE WEIGHT
O
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Fig. 2: Muscle weight. The muscle weight of the tibialis anterior muscle is expressed as the ratio of the operated
tibialis anterior muscle weight compared to the non-operated control limb.
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ratios between any of the grafted groups; how-
ever, the gap control group was significantly
lower than the grafted groups (0.18 _+ 0.09, p <
0.01). The pattern for the hydroxyproline con-
centration (Fig. 3) was similar to the results of
the flexion contracture in that the group with
pretreated allografts but no immunosuppression
(Group F) had a lower hydroxyproline concen-
tration (1.52 _+ 0.16) than the allografted group
with no pretreatment or immunosuppression
(1.68 __. 0.34, Group D) or the ungrafted group
(Group H, 4.50 +_ 0.27, p < 0.01), but a higher
hydroxyproline concentration than the groups
with either isografts or allografts with immuno-
suppression (Groups A, B, C, E and G, p <
0.01). Similarly, there were no significant differ-
ences between the isografted groups or the allo-
grafted groups with immunosuppression. There
was no significant difference between the allo-
grafted group that received immunosuppression
plus a pretreated graft (Group G) versus Group
E which received an allograft with only immuno-
suppression of the host.
FIGURE 3- HYDROXYPROLINE CONCENTRATION
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Hydroxyproline concentration. The results are expressed as the ratio ol the hydroxyproline concentration
in the operated limb tibialis anterior muscle compared to the non-operated control limb.
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Histologie studies
All grafted groups showed evidence of axonal
ingrowth both into the graft and across the distal
coaptation site. In general, the axons in the graft
were smaller, more variable in size, more widely
spaced, and greater in number than those in the
contralateral nerve. There was wide variability in
the degree of myelination as some axons had
well-developed sheaths while others had only
thin myelin coats. Only the group with allografts
without either pretreated grafts or host
immunosuppression (Group D) had an axonal
density ratio of <1 although this was not a
statistically significant difference (Fig. 4). There
were mild inflammatory changes in all nerve
grafts as noted below:
% area with inflammatory
Group, cells/normal nerve
A 7.3% +_ 4.7%
B 5.6% _+ 6.2%
C 8.1%+_ 8.0%
D 9.6% _+ 10.9%
E 6.3% _. 2.4%
F 3.6%+_ 4.3%
G 15.8% +__ 7.4%
H 3.4% _.+ 3.8%
No significant differences
between the different groups.
were noted
Serum cyclosporin-A assay
All animals receiving cyclosporin had
satisfactory serum levels which ranged from 650
to 1,020 ng/ml.
DISCUSSION
Despite the ability to transplant many other
cadaveric tissues, nerve transplantation is not
performed clinically. Although cyclosporin-A has
greater efficacy when compared to azathioprine
and corticosteroids, it also has greater systemic
toxicity. The results of this study demonstrate
that animals receiving predegenerated grafts had
smaller hind limb flexion contractures and lower
hydroxproline ratios of the tibialis anterior
muscle as compared to the values obtained from
animals without either cyclosporin-A or pre-
treatment. However, the animals with immuno-
suppression had greater neurologic recovery
than did the animals with predegenerated grafts
and no immunosuppression. There were no sig-
nificant differences between the isografted
groups with cyclosporin or without, indicating
that cyclosporin itself does not have an inhibitory
characteristic on post-surgical inflammation and
fibrosis of muscle tissue. All grafted animals
demonstrated some neurological recovery when
compared to the non-grafted control group. The
sensory testing and gait analyses did not appear
to be reliable studies in this model that involved
grafting a large segment of the sciatic nerve in
the animals. The results of the sensory tests were
consistent with crossover innervation from the
saphenous nerve which has been described pre-
viously /34/. In their description of the sciatic
function index which quantifies the gait analysis,
deMedinaceli et al. /29/were unable to note sig-
nificant return of foot intrinsic muscles, even
after simple transsection repair of the sciatic
nerve, although they noted excellent functional
recovery following lesions in continuity such as a
crush injury. Bain and MacKinnon /36/ did
report success using a modification of
deMedinaceli’s technique. In a careful eval-
uation of this technique, Terzis and Smith/30/
noted that the return of the function of the
intrinsic muscles in the foot was the only reliable
portion of the sciatic function index. None of the
animals in our study obtained return of function
of the foot intrinsic muscles. The animals had
ample time for nerve regeneration to the level of
the foot based on the site of the most proximal
portion of the lesion. In preliminary studies with
observation for up to six months, no recovery of
the foot intrinsic muscles was noted when large
grafts were placed in an intercalary fashion in the
sciatic nerve. The evaluation of the hind limb
flexion contractures may have been a more sen-
sitive indicator because these contractures are
time-dependent. Animals that have a faster re-
covery will probably have a smaller hind limb
flexion contracture even though two groups of
animals ultimately have similar numbers of axons
reinnervating the end organs. This may explain
why the hind limb flexion contractures and the
hydroxyproline concentrations (a measure of
fibrosis of muscle tissue) demonstrated signifi-
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cant differences, whereas the studies of muscle
weights and axonal counts did not. From the his-
tologic studies it appears that the rejection of
intercalary grafts is not as dramatic as originally
proposed /12,13,15,16/. This again may be re-
lated to the fact that the differences between the
groups were based on the speed of reinnerva-
tion, not the ultimate quantity of regeneration of
the axons reaching the end organs. Grafts with
less immunogenicity or with host immunosup-
pression may maintain larger numbers of
Schwann cells that facilitate faster regeneration
but ultimately the grafts allow similar numbers of
axons to reach the motor and sensory end or-
gans. This is highlighted by the fact that there
were not significant differences in the inflamma-
tory cell migration into the grafts between the
different groups.
The mechanism by which Wallerian degener-
ation could affect the immunogenicity of the
O
FIGURE 4 AXONAL DENSITY RATIOS
.o6
Group A Group B ;Clal Group D Group E Group F
Iso Iso/CyA Iso/W AIIo AIIo/CyA AIIo/WII
|,i_,,,| _,,,,|ll
1.22
;:i:’;’,
,:,:|:0:,
:,:,:,:,
,,:-:,,:-:-,
GroupG
Alio/CyA/
Wall
Fig. 4: Axonal density ratios. The axonal density ratio in the nerve segments are expressed as the ratio of the
axonal density in the mid portion of the nerve segment of the operated limb compared to the
corresponding segment of the sciatic nerve in the non-operated control limb.
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grafts is two-fold. On one hand, the
histocompatibility antigens may be less
accessible or not expressed as strongly during the
process of Wallerian degeneration and con-
version of Schwann cells to become phagocytic
cells. This may occur for either Class I or Class II
antigens. In the evaluation of the effect of
trauma on major histocompatibility Class II
antigens, an increase in the expression of the
antigens was noted following nerve division and
Wallerian degeneration /37/. Presumably these
antigens which are increased in their expression
are also available for recognition by the host.
This places some doubt on the importance of
MHC Class II antigens in the recognition of a11o-
geneic peripheral nerve tissue. The effect of
trauma on the expression of major histo-
compatibility Class I antigens has not been
demonstrated.
On the other hand, the predegenerated graft
may allow for more rapid replacement of donor
Schwann cells by host Schwann cells. Once this
process is completed, the graft would then be
rendered non-immunogenic. There is very little
information on the use of predegenerated grafts.
Gordon et al. /38/ demonstrated an improvement
in chronic nerve injuries which were treated with
predegenerated syngeneic grafts but not in acute
injuries. Predegenerated grafts do not appear to
improve neurologic recovery in this study of an
acute segmental loss of the nerve by providing
activated Schwann cells that enhance overall
regeneration as the pretreated grafts did not
improve the regeneration following syngeneic
transplantation. The use of predegenerated
grafts does have the added complexity of
requiring donors who have had prior nerve
injuries or from living donors.
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